Jack de la Torre, MD, PhD
Affiliations: | Sun Health Research Institute, Sun City, AZ, United States |
Website:
http://www2.kenes.com/adpd2009/speakers_bio/Jack_de_la_Torre.pdfGoogle:
"Jack de la Torre"Bio:
http://www.faqs.org/patents/inv/71556
http://www.dmso.org/articles/information/muir.htm
Mean distance: 106866
Cross-listing: Alzheimer's Tree
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Obrenovich ME, Smith MA, Siedlak SL, et al. (2006) Overexpression of GRK2 in Alzheimer disease and in a chronic hypoperfusion rat model is an early marker of brain mitochondrial lesions. Neurotoxicity Research. 10: 43-56 |
Aliyev A, Chen SG, Seyidova D, et al. (2005) Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease. Journal of the Neurological Sciences. 229: 285-92 |
Liu Q, Smith MA, Avilá J, et al. (2005) Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations. Free Radical Biology & Medicine. 38: 746-54 |
Aliev G, Smith MA, de la Torre JC, et al. (2004) Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimer's disease. Mitochondrion. 4: 649-63 |
de la Torre J, Aliev G, Perry G. (2004) Drug therapy in Alzheimer's disease. The New England Journal of Medicine. 351: 1911-3; author reply |
Seyidova D, Aliyev A, Rzayev N, et al. (2004) The role of nitric oxide in the pathogenesis of brain lesions during the development of Alzheimer's disease. In Vivo (Athens, Greece). 18: 325-33 |
Aliyev A, Seyidova D, Rzayev N, et al. (2004) Is nitric oxide a key target in the pathogenesis of brain lesions during the development of Alzheimer's disease? Neurological Research. 26: 547-53 |
Aliev G, Smith MA, Obrenovich ME, et al. (2003) Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Azheimer disease. Neurotoxicity Research. 5: 491-504 |